Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

AUPHAUPH

Showing 8 of 31 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in Aurinia Pharmaceuticals Inc

No. Hudson Bay Capital Management exited its AUPH (Aurinia Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 85,000 shares worth $1.3M. Hudson Bay Capital Management already held AUPH in its Q4 2018 13F, the earliest on record, and held it in 30 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.1M

Total Shares Change

-280,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$16.97
0
2026-Q1
Unchanged
85,000
0.0%
$1.3M0.0%$14.15
0
2025-Q4
Increased
85,000
+0.9%
$1.4M0.0%$15.95
26
2025-Q3
Decreased
84,218
-19.0%
$930,6090.0%$11.05
0
2025-Q2
Increased
104,000
+4.0%
$880,8800.0%$8.47
26
2025-Q1
Increased
100,000
+17.6%
$804,0000.0%$8.29
29
2024-Q4
Decreased
85,000
-69.6%
$763,3000.0%$9.17
0
2024-Q3
Decreased
280,000
-17.6%
$2.1M0.0%$7.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used